Annis Gardner Whiting Capital Advisors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.16M Sell
14,742
-527
-3% -$42.5K 0.17% 103
2026
Q1
$1.33M Buy
15,269
+4
+0% +$383 0.21% 79
2025
Q4
$1.47M Buy
15,265
+3,650
+31% +$355K 0.28% 64
2025
Q3
$1.11M Sell
11,615
-9
-0.1% -$827 0.23% 77
2025
Q2
$1.02M Buy
11,624
+266
+2% +$22.6K 0.35% 61
2025
Q1
$1.03M Sell
11,358
-81
-0.7% -$7.25K 0.43% 50
2024
Q4
$921K Sell
11,439
-65
-0.6% -$5.63K 0.26% 74
2024
Q3
$1.04M Buy
11,504
+344
+3% +$28.9K 0.29% 62
2024
Q2
$886K Buy
11,160
+8,723
+358% +$715K 0.25% 75
2024
Q1
$219K Buy
2,437
+27
+1% +$2.3K 0.08% 175
2023
Q4
$200K Buy
2,410
+1,084
+82% +$82.6K 0.09% 153
2023
Q3
$105K Buy
+1,326
New +$111K 0.06% 201

Other funds holding MDT

Annis Gardner Whiting Capital Advisors's MDT Position: Q2 2026 in Review

Annis Gardner Whiting Capital Advisors reduced its Medtronic (MDT) stake by 3.5% in Q2 2026, selling an estimated $42.5K and leaving 14,742 shares worth $1.16M. The position accounts for 0.17% of the portfolio, ranked #103.

Annis Gardner Whiting Capital Advisors first reported a position in MDT in Q3 2023 and has held it in 12 quarters since. The position peaked at $1.47M in Q4 2025. 2,128 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Annis Gardner Whiting Capital Advisors held 14,742 shares of Medtronic worth $1.16M as of Q2 2026.
  • Annis Gardner Whiting Capital Advisors sold 527 Medtronic shares in Q2 2026, an estimated $42.5K.
  • Medtronic made up 0.17% of Annis Gardner Whiting Capital Advisors's portfolio in Q2 2026, its #103 holding.
  • Annis Gardner Whiting Capital Advisors first reported a position in Medtronic in Q3 2023 and has held it in 12 quarters since.
  • Annis Gardner Whiting Capital Advisors's Medtronic position peaked at $1.47M in Q4 2025.
  • 2,128 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Annis Gardner Whiting Capital Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.